Author details

Full Name

Kim E Nichols

Affiliation

St. Jude Children's Research Hospital

ORCID

Career Start Year

1986

Papers

241

H Index

Expertise

CM4AI Collaborator

Antoine Forget (CM4AI)

PMID	Paper Title	Journal Title	Published Year
37823831	Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.	Cancer Discov	2024
37548271	Constitutional balanced translocations involving SMARCB1: A rare cause of rhabdoid tumor predisposition syndrome.	Genes Chromosomes Cancer	2024
37992218	Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation.	Blood	2024
36913308	Proof-of-principle: targeted childhood leukemia prevention.	Oncotarget	2023
37487610	The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).	Ann Rheum Dis	2023
37522715	ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in mice.	Blood Adv	2023
37797633	Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study.	Lancet Oncol	2023
37620322	Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice.	Nat Commun	2023
37944075	Parent Quality of Life After Disclosure of Pediatric Oncology Germline Sequencing Results.	JCO Precis Oncol	2023
37971762	Hyperactive TLR signaling: putting the "H" in HÂ syndrome.	Blood	2023
37869077	Germline landscape of <i>RPA1, RPA2 and RPA3</i> variants in pediatric malignancies: identification of <i>RPA1</i> as a novel cancer predisposition candidate gene.	Front Oncol	2023
35652336	Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor.	Neuro Oncol	2023
36993649	The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study.	Res Sq	2023
37191489	MRI Features for Identifying <i>MYCN</i>-amplified <i>RB1</i> Wild-type Retinoblastoma.	Radiology	2023
37023453	How I communicate with patients and families about germ line genetic information.	Blood	2023
37279817	Adolescent and Young Adult Understanding of Their Childhood Cancer Predisposition Diagnosis: A Qualitative Study.	J Pediatr	2023
37377903	Multiple Germline Events Contribute to CancerÂ Development in Patients with Li-Fraumeni Syndrome.	Cancer Res Commun	2023
37073685	Germline genomic findings in children and young adults with melanocytic tumors.	Pediatr Blood Cancer	2023
37166930	Deciphering genetic uncertainty in familial HLH.	Blood	2023
36969228	Insights into the cellular pathophysiology of familial hemophagocytic lymphohistiocytosis.	Front Immunol	2023
37228616	Cellular and transcriptional impacts of Janus kinase and/or IFN-gamma inhibition in a mouse model of primary hemophagocytic lymphohistiocytosis.	Front Immunol	2023
36813544	Germline pathogenic <i>SMARCA4</i> variants in neuroblastoma.	J Med Genet	2023
36693186	Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management.	Clin Cancer Res	2023
34675114	Clinical and Functional Significance of TP53 Exon 4-Intron 4 Splice Junction Variants.	Mol Cancer Res	2022
35479646	Towards the prevention of childhood leukemia.	Oncoscience	2022
35471132	Managing Pandora's Box: Familial Expectations around the Return of (Future) Germline Results.	AJOB Empir Bioeth	2022
37090027	Case Series: Neurobehavioral Profile of Adolescents with PTEN Hamartoma Tumor Syndrome.	J Pediatr Neuropsychol	2022
36001348	Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer Predisposition.	Cancer Prev Res (Phila)	2022
36206094	Recent advances in the treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.	Curr Opin Allergy Clin Immunol	2022
36265116	Parental Preferences Surrounding Timing and Content of Consent Conversations for Clinical Germline Genetic Testing Following a Child's New Cancer Diagnosis.	JCO Precis Oncol	2022
35131871	Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice.	Cancer Res	2022
34996063	Development of BRAFV600E-positive acute myeloid leukemia in a patient on long-term dabrafenib for multisystem LCH.	Blood Adv	2022
34992263	Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.	Nat Med	2022
34710216	CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies.	Blood Adv	2022
32693409	Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia.	Blood	2021
33624449	Creating a cancer genomics curriculum for pediatric hematology-oncology fellows: A national needs assessment.	Cancer Med	2021
33737307	Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials.	Clin Cancer Res	2021
33664745	Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.	Front Immunol	2021
33579957	The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms.	Nat Commun	2021
33856445	RHOG: Rac1-ing up another HLH gene.	Blood	2021
33914076	HLH or sepsis: the truth is in the T cells.	Blood	2021
34868048	Digenic Inheritance: Evidence and Gaps in Hemophagocytic Lymphohistiocytosis.	Front Immunol	2021
34617981	Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.	JAMA Oncol	2021
34473566	Identifying Childhood Cancer Survivors at Increased Genetic Risk for Second Malignant Neoplasms: Use of a Novel Screening Tool.	J Clin Oncol	2021
34709361	Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.	JAMA Oncol	2021
34301788	Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.	Cancer Discov	2021
34127338	Knowledge Is Power: Benefits, Risks, Hopes, and Decision-Making Reported by Parents Consenting to Next-Generation Sequencing for Children and Adolescents with Cancer.	Semin Oncol Nurs	2021
33981229	Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm in Experimental Models of Hyperinflammation Syndrome.	Front Pharmacol	2021
34263927	Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy.	Br J Haematol	2021
34166225	Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia.	J Clin Invest	2021

1 - 50 of 241

Hiroko Tanaka

Tokyo Medical and Dental University

Career Start Year 2012

Number of shared co-authors 4

Alexandra E Kovach

Children's Hospital of Los Angeles

Career Start Year 2008

Number of shared co-authors 2

Kara L Davis

Stanford University School of Medicine

Career Start Year 2008

Number of shared co-authors 11

Jennifer Dunlap

Oregon Health & Science University

Career Start Year 2008

Number of shared co-authors 8

Fabian Hauck

Department of Pediatrics at the Dr. von Hauner Children's Hospital

Career Start Year 2008

Number of shared co-authors 4

Linghua Wang

The University of Texas M. D. Anderson

Career Start Year 2006

Number of shared co-authors 6

Julia Carnevale

University of California san francisco

Career Start Year 2006

Number of shared co-authors 0

Michael Gombert

Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf

Career Start Year 2004

Number of shared co-authors 17

Melita Irving

Guy's and St Thomas' NHS Foundation Trust, Evelina Children's Hospital

Career Start Year 2001

Number of shared co-authors 1

Jacqueline E Payton

Washington University School of Medicine.

Career Start Year 2001

Number of shared co-authors 10

Guang Fan

Oregon Health and Science University

Career Start Year 2000

Number of shared co-authors 8

Scott C Borinstein

Vanderbilt University Medical Center

Career Start Year 1998

Number of shared co-authors 2

Lawrence J Jennings

Northwestern University Feinberg School of Medicine

Career Start Year 1998

Number of shared co-authors 10

Markus G Seidel

Medical University of Graz

Career Start Year 1998

Number of shared co-authors 6

Shashikant Kulkarni

Centene Center for Health Transformation, Centene Corporation

Career Start Year 1998

Number of shared co-authors 20

David M Weinstock

Merck & Co.

Career Start Year 1998

Number of shared co-authors 13

Stephanie Halene

Smilow Cancer Center, Yale University School of Medicine

Career Start Year 1997

Number of shared co-authors 4

Eric Tse

School of Clinical Medicine, University of Hong Kong

Career Start Year 1997

Number of shared co-authors 2

Francisco Vega

The University of Texas MD Anderson Cancer Center

Career Start Year 1996

Number of shared co-authors 7

Austen Worth

Great Ormond Street Hospital for Children NHS Foundation Trust

Career Start Year 1995

Number of shared co-authors 2

Yongjin Li

Mayo Clinic

Career Start Year 1995

Number of shared co-authors 56

Seishi Ogawa

Kyoto University

Career Start Year 1993

Number of shared co-authors 13

Christoph Klein

Kinderklinik und Kinderpoliklinik der Ludwig-Maximilians-Universitat Munchen

Career Start Year 1993

Number of shared co-authors 3

Christopher D Gocke

Johns Hopkins University School of Medicine

Career Start Year 1992

Number of shared co-authors 1

Ute Fischer

Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf

Career Start Year 1992

Number of shared co-authors 20

Arndt Borkhardt

Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf

Career Start Year 1992

Number of shared co-authors 40

Giorgio Inghirami

Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital

Career Start Year 1984

Number of shared co-authors 12

Phuong Nguyen

Hoag Memorial Hospital Presbyterian

Career Start Year 1983

Number of shared co-authors 6

Timothy J Ley

Washington University School of Medicine

Career Start Year 1982

Number of shared co-authors 29

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 45

row(s) 1 - 30 of 30